Published in Nature on May 22, 1975
Cellular immunity against Semliki Forest virus in mice. Infect Immun (1979) 0.89
Relationship between antigenic stimulation and increased splenic peroxidase levels during the immune response. Infect Immun (1977) 0.78
A phase II study of temozolomide vs. procarbazine in patients with glioblastoma multiforme at first relapse. Br J Cancer (2000) 4.96
An infectious molecular clone of an unusual macrophage-tropic and highly cytopathic strain of human immunodeficiency virus type 1. J Virol (1992) 4.85
A1, Cw7, B8, DR3 HLA antigen combination associated with rapid decline of T-helper lymphocytes in HIV-1 infection. A report from the Multicenter AIDS Cohort Study. Lancet (1990) 2.89
Growth inhibition of Candida albicans by human polymorphonuclear neutrophils: activation by interferon-gamma and tumor necrosis factor. J Immunol (1986) 2.37
Growth of Legionella pneumophila in thioglycolate-elicited peritoneal macrophages from A/J mice. Infect Immun (1988) 2.37
The importance of measuring cotinine levels to identify smokers in clinical trials. Clin Pharmacol Ther (1994) 2.11
A methylthioadenosine phosphorylase (MTAP) fusion transcript identifies a new gene on chromosome 9p21 that is frequently deleted in cancer. Oncogene (2000) 2.07
The sensitivity of auditory brainstem response testing in small acoustic neuromas. Laryngoscope (1992) 2.06
Direct localization and visualization of hyaluronate lyase activity by agar gel electrophoresis. Proc Soc Exp Biol Med (1967) 2.00
There is no role for hyperfractionated radiotherapy in the management of children with newly diagnosed diffuse intrinsic brainstem tumors: results of a Pediatric Oncology Group phase III trial comparing conventional vs. hyperfractionated radiotherapy. Int J Radiat Oncol Biol Phys (1999) 1.96
Neurodevelopment and predictors of outcomes of children with birth weights of less than 1000 g: 1992-1995. Arch Pediatr Adolesc Med (2000) 1.95
Sexual initiation: predictors and developmental trends. Sex Transm Dis (2001) 1.85
Enhanced susceptibility of penicillin-resistant staphylococci to phagocytosis after in vitro incubation with low doses of nafcillin. Proc Soc Exp Biol Med (1974) 1.76
Involvement of nicotinic acetylcholine receptors in suppression of antimicrobial activity and cytokine responses of alveolar macrophages to Legionella pneumophila infection by nicotine. J Immunol (2001) 1.74
Protective effects of tumor necrosis factor in experimental Legionella pneumophila infections of mice via activation of PMN function. J Leukoc Biol (1988) 1.73
Rat insulin-like growth factor II gene. A single gene with two promoters expressing a multitranscript family. J Mol Biol (1986) 1.72
Tumor necrosis factor induction by Candida albicans from human natural killer cells and monocytes. J Immunol (1988) 1.70
Effect of phenylbutazone on phagocytosis and intracellular killing by guinea pig polymorphonuclear leukocytes. J Bacteriol (1968) 1.69
Function of h(2)o(2), myeloperoxidase, and hexose monophosphate shunt enzymes in phagocytizing cells from different species. Infect Immun (1970) 1.69
Differences in HLA class II alleles of isolated South American Indian populations from Brazil and Argentina. Hum Immunol (1993) 1.69
Smith-Lemli-Opitz syndrome: a variable clinical and biochemical phenotype. J Med Genet (1998) 1.65
Macrophage-tropic strains of human immunodeficiency virus type 1 utilize the CD4 receptor. J Virol (1990) 1.65
Interferon-gamma induction by lipopolysaccharide: dependence on interleukin 2 and macrophages. J Immunol (1986) 1.62
Effects of RES "blockade" on antibody-formation. I. Suppressed cellular and humoral haemolysin responses in mice injected with carbon particles. Immunology (1969) 1.61
Radiometric detection of bacteremia: requirement for terminal subcultures. J Clin Microbiol (1977) 1.61
Oxidative peptide cleavage and decarboxylation by the MPO-H2O2-Cl- antimicrobial system. Infect Immun (1974) 1.58
Bacterial heat shock proteins directly induce cytokine mRNA and interleukin-1 secretion in macrophage cultures. Infect Immun (1994) 1.54
The presence of Campylobacter pylori in nonsteroidal antiinflammatory drug associated gastritis. J Rheumatol (1989) 1.51
Role of the phagocyte in host-parasite interactions. XXII. H2O2-dependent decarbosylation and deamination by myeloperoxidase and its relationship to antimicrobial activity. J Reticuloendothel Soc (1970) 1.49
Cryptococcal capsular polysaccharide-induced modulation of murine immune responses. Infect Immun (1982) 1.47
Fatigue in Parkinson's disease. Neurology (1993) 1.46
Role of the Phagocyte in Host-Parasite Interactions XXIV. Aldehyde Generation by the Myeloperoxidase-H(2)O(2)-Chloride Antimicrobial System: a Possible In Vivo Mechanism of Action. Infect Immun (1970) 1.46
Legionella pneumophila-induced blastogenesis of murine lymphoid cells in vitro. Infect Immun (1984) 1.39
Antibiotic use for the treatment of upper respiratory infections in a diverse community. J Fam Pract (1999) 1.39
Comparison of sampling methods for obtaining accurate coagulation values in hemodialysis patients with heparinized central venous catheters. Nephrol Nurs J (2001) 1.38
Variability of X-ray emission from M87. Nature (1971) 1.38
Building collaborative relationships with families of the mentally ill. Hosp Community Psychiatry (1988) 1.38
Vibrio vulnificus resists phagocytosis in the absence of serum opsonins. Infect Immun (1985) 1.35
Massage therapy for patients undergoing autologous bone marrow transplantation. J Pain Symptom Manage (1999) 1.32
Temperature control of initiation of protein synthesis in Escherichia coli. J Mol Biol (1971) 1.32
Immunosuppressive effects of Friend and Rauscher leukemia disease viruses on cellular and humoral antibody formation. J Natl Cancer Inst (1968) 1.31
Enhancement of human monocyte function against Candida albicans by the colony-stimulating factors (CSF): IL-3, granulocyte-macrophage-CSF, and macrophage-CSF. J Immunol (1989) 1.30
Outcomes of extremely low birth weight infants. Pediatrics (1996) 1.28
Delta 9-tetrahydrocannabinol treatment suppresses immunity and early IFN-gamma, IL-12, and IL-12 receptor beta 2 responses to Legionella pneumophila infection. J Immunol (2000) 1.28
Spatial learning impairment in mice infected with Legionella pneumophila or administered exogenous interleukin-1-beta. Brain Behav Immun (1995) 1.28
The cannabinoid system and cytokine network. Proc Soc Exp Biol Med (2000) 1.27
Inhibition of Legionella pneumophila growth by gamma interferon in permissive A/J mouse macrophages: role of reactive oxygen species, nitric oxide, tryptophan, and iron(III). Infect Immun (1994) 1.27
Viral hepatitis, type A. Identification by specific complement fixation and immune adherence tests. N Engl J Med (1975) 1.25
A PCR specific for Escherichia coli O157 based on the rfb locus encoding O157 lipopolysaccharide. J Clin Microbiol (1998) 1.24
Population study of triazolam pharmacokinetics. Br J Clin Pharmacol (1986) 1.24
An epitope in the third hypervariable region of the DRB1 gene is involved in the susceptibility to endemic pemphigus foliaceus (fogo selvagem) in three different Brazilian populations. Tissue Antigens (1997) 1.24
Immunosuppression by leukemia viruses. I. Effect of Friend disease virus on cellular and humoral hemolysin responses of mice to a primary immunization with sheep erythrocytes. J Immunol (1968) 1.23
The role of the phagocyte in host-parasite interactions. 23. Relation of bactericidal activity to peroxidase-associated decarboxylation and deamination. Biochem Biophys Res Commun (1970) 1.21
Differential growth of Legionella pneumophila in guinea pig versus mouse macrophage cultures. Infect Immun (1987) 1.21
Marijuana, immunity and infection. J Neuroimmunol (1998) 1.21
Secondary immunity to Legionella pneumophila and Th1 activity are suppressed by delta-9-tetrahydrocannabinol injection. Infect Immun (1994) 1.21
Role of the phagocyte in host-parasite interactions. 38. Metabolic activities of the phagocyte as related to antimicrobial action. J Reticuloendothel Soc (1972) 1.20
Differential complement activation and susceptibility to human serum bactericidal action by Vibrio species. Infect Immun (1983) 1.20
Variation in antigenic determinants of p53 transformation-related protein obtained from various species. J Immunol (1983) 1.19
Biochemical aspects of phagocytic cells as related to bactericidal function. J Reticuloendothel Soc (1972) 1.19
Dorsal column stimulation for control of pain. Preliminary report on 30 patients. J Neurosurg (1972) 1.18
Cannabinoid receptors and immunity. Immunol Today (1998) 1.17
Induction of interferon-gamma and tumor necrosis factor by Legionella pneumophila: augmentation of human neutrophil bactericidal activity. J Leukoc Biol (1989) 1.17
Comparison of a radiometric procedure with conventional methods for identification of Neisseria. J Clin Microbiol (1978) 1.17
MR imaging of high-grade cerebral gliomas: value of diffusion-weighted echoplanar pulse sequences. AJR Am J Roentgenol (1994) 1.17
Electromicturition in paraplegia. Implantation of a spinal neuroprosthesis. Arch Surg (1972) 1.15
Immunosuppression induced in vitro by mastocytoma tumor cells and cell-free extracts. J Immunol (1975) 1.14
The biochemical and antimicrobial activities of phagocytizing cells. Am J Clin Nutr (1971) 1.14
Cytolytic activity of human peripheral blood leukocytes against Legionella pneumophila-infected monocytes: characterization of the effector cell and augmentation by interleukin 2. J Immunol (1987) 1.14
Modulation of in vivo antibody responses by cholera toxin. J Immunol (1975) 1.14
Immunologic tolerance to Escherichia coli somatic antigen assessed by bacteriolytic and hemolytic plaque assays. J Immunol (1970) 1.13
Interferon-gamma induced resistance to Legionella pneumophila in susceptible A/J mouse macrophages. J Leukoc Biol (1991) 1.13
The role of the phagocyte in host-parasite interactions. XIX. Leukocytic glutathione reductase and its involvement in phagocytosis. Arch Biochem Biophys (1969) 1.13
Role of gamma interferon in induction of natural killer activity by Legionella pneumophila in vitro and in an experimental murine infection model. Infect Immun (1988) 1.12
The effect of RES blockade on cellular antibody formation to sheep erythrocytes. Proc Soc Exp Biol Med (1968) 1.12
Dissociation between the adjuvant vs mitogenic activity of a synthetic muramyl dipeptide for murine splenocytes. Proc Soc Exp Biol Med (1977) 1.12
Ribosomal subunits produced by cold sensitive initiation of protein synthesis. Nature (1969) 1.11
Direct involvement of NADPH oxidase with the stimulated respiratory and hexose monophosphate shunt activities in phagocytizing leukocytes. Exp Cell Res (1972) 1.11
Paclitaxel for the treatment of progressive or recurrent childhood brain tumors: a pediatric oncology phase II study. J Pediatr Hematol Oncol (2001) 1.10
Multiple low-dose streptozocin-induced diabetes in NOD-scid/scid mice in the absence of functional lymphocytes. Diabetes (1994) 1.10
Cellular basis for the immunosuppressive properties of a leukaemogenic virus. Nature (1968) 1.09
The pharmacokinetics of doxylamine: use of automated gas chromatography with nitrogen-phosphorus detection. J Clin Pharmacol (1985) 1.08
Cosmic X-ray Sources. Science (1965) 1.08
Binding of Legionella pneumophila to macrophages increases cellular cytokine mRNA. Infect Immun (1994) 1.08
The metabolic and phagocytic activities of leukocytes from children with acute leukemia. Cancer Res (1970) 1.08
Transactivation of the major capsid protein gene of herpes simplex virus type 1 requires a cellular transcription factor. J Virol (1992) 1.08
Lymphoid cell blastogenesis as an in vitro indicator of cellular immunity to Legionella pneumophila antigens. J Clin Microbiol (1984) 1.08
A rapid [3H]glucose incorporation assay for determination of lymphoid cell-mediated inhibition of Candida albicans growth. J Immunol Methods (1986) 1.08
Antibody-mediated bacteriolysis: enhanced killing of cyclacillin-treated bacteria. Proc Soc Exp Biol Med (1976) 1.07
Transient lateral patellar dislocation: diagnosis with MR imaging. AJR Am J Roentgenol (1993) 1.07
Perinatal correlates of cerebral palsy and other neurologic impairment among very low birth weight children. Pediatrics (1998) 1.06
Migration of mouse lymphocytes in vitro from capillary tube cultures. Proc Soc Exp Biol Med (1969) 1.06
Development of antibody-forming cells in neonatal mice: stimulation and inhibition by calf thymus fractions. J Immunol (1970) 1.06
Immunosuppression and the role of suppressive factors in cancer. Adv Cancer Res (1977) 1.06
Stimulation of an enhanced in vitro immune response by a synthetic adjuvant, muramyl dipeptide. J Immunol (1978) 1.06